ABOS Acumen Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABOS

Price (delayed)

$2.285

Market cap

$165.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.86

Enterprise value

$144.06M

?
Relative Growth: Rel. Growth: 9
Relative Strength: Rel. Strength: 76
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 6
Highlights
Acumen Pharmaceuticals's EPS has increased by 7% from the previous quarter and by 4.1% YoY
Acumen Pharmaceuticals's net income has increased by 7% from the previous quarter and by 2.6% YoY
The company's equity fell by 44% YoY but it rose by 24% QoQ
The company's quick ratio fell by 43% YoY but it rose by 13% QoQ
The company's debt rose by 5% YoY
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ABOS

ABOS stock price

How has the Acumen Pharmaceuticals stock price performed over time
Intraday
-0.22%
1 week
-10.04%
1 month
-7.86%
1 year
113.55%
YTD
8.29%
QTD
-3.18%

Financial performance

How have Acumen Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$114.61M
Net income
-$113.28M
Gross margin
N/A
Net margin
N/A
Acumen Pharmaceuticals's operating income has increased by 9% YoY and by 7% QoQ
Acumen Pharmaceuticals's net income has increased by 7% from the previous quarter and by 2.6% YoY

Price vs fundamentals

How does ABOS's price correlate with its fundamentals

Growth

What is Acumen Pharmaceuticals's growth rate over time

Valuation

What is Acumen Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Acumen Pharmaceuticals's EPS has increased by 7% from the previous quarter and by 4.1% YoY
The P/B is 72% more than the 5-year quarterly average of 1.1 and 35% more than the last 4 quarters average of 1.4
The company's equity fell by 44% YoY but it rose by 24% QoQ

Efficiency

How efficient is Acumen Pharmaceuticals business performance
ABOS's ROIC has plunged by 113% YoY and by 17% from the previous quarter
ABOS's return on equity has dropped by 112% year-on-year and by 11% since the previous quarter
ABOS's ROA has dropped by 71% year-on-year and by 4.9% since the previous quarter

Dividends

What is ABOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABOS.

Financial health

How did Acumen Pharmaceuticals financials performed over time
Acumen Pharmaceuticals's total assets is 190% more than its total liabilities
The company's quick ratio fell by 43% YoY but it rose by 13% QoQ
ABOS's current ratio is down by 43% year-on-year but it is up by 12% since the previous quarter
The company's debt is 65% lower than its equity
The debt to equity has soared by 84% YoY but it has contracted by 20% from the previous quarter
The company's equity fell by 44% YoY but it rose by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.